Fractyl Health, Inc. (GUTS) SEC filings

GUTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30

$0.90+0.09 (+11.27%)

Close on Nov 13, 2026Market cap $11.99MP/E –Yield –

SEC filings

40 of Fractyl Health's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 12, 2026	SEC EDGAR
Current report	8-K	Nov 12, 2026	Nov 12, 2026	SEC EDGAR
Current report	8-K	Nov 2, 2026	Nov 6, 2026	SEC EDGAR
Current report	8-K	Oct 21, 2026	Oct 22, 2026	SEC EDGAR
Current report	8-K	Oct 16, 2026	Oct 16, 2026	SEC EDGAR
Current report	8-K	Sep 30, 2026	Oct 1, 2026	SEC EDGAR
Current report	8-K	Sep 24, 2026	Sep 24, 2026	SEC EDGAR
Current report	8-K	Sep 10, 2026	Sep 11, 2026	SEC EDGAR
Proxy statement	DEF 14A	Aug 24, 2026	Aug 24, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	Aug 10, 2026	Aug 10, 2026	SEC EDGAR
Current report	8-K	Jul 15, 2026	Jul 15, 2026	SEC EDGAR
Current report	8-K	Jun 10, 2026	Jun 11, 2026	SEC EDGAR
Current report	8-K	Jun 4, 2026	Jun 4, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 12, 2026	SEC EDGAR
Current report	8-K	May 12, 2026	May 12, 2026	SEC EDGAR
Current report	8-K	May 11, 2026	May 11, 2026	SEC EDGAR
Proxy statement	DEF 14A	Apr 23, 2026	Apr 24, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 24, 2026	SEC EDGAR
Current report	8-K	Mar 24, 2026	Mar 24, 2026	SEC EDGAR
Current report	8-K	Mar 13, 2026	Mar 17, 2026	SEC EDGAR
Current report	8-K	Feb 26, 2026	Feb 26, 2026	SEC EDGAR
Current report	8-K	Jan 29, 2026	Jan 29, 2026	SEC EDGAR
Current report	8-K	Dec 30, 2025	Jan 6, 2026	SEC EDGAR
Current report	8-K	Jan 5, 2026	Jan 5, 2026	SEC EDGAR
Current report	8-K	Dec 15, 2025	Dec 16, 2025	SEC EDGAR
Current report	8-K	Dec 2, 2025	Dec 2, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 12, 2025	SEC EDGAR
Current report	8-K	Nov 12, 2025	Nov 12, 2025	SEC EDGAR
Current report	8-K	Oct 3, 2025	Oct 3, 2025	SEC EDGAR
Current report	8-K	Sep 26, 2025	Sep 26, 2025	SEC EDGAR
Current report	8-K	Sep 26, 2025	Sep 26, 2025	SEC EDGAR
Current report	8-K	Aug 29, 2025	Sep 3, 2025	SEC EDGAR
Proxy statement	DEF 14A	Oct 3, 2025	Aug 25, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 12, 2025	SEC EDGAR
Current report	8-K	Aug 12, 2025	Aug 12, 2025	SEC EDGAR
Current report	8-K	Aug 6, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	Jun 23, 2025	Jun 23, 2025	SEC EDGAR
Current report	8-K	Jun 18, 2025	Jun 18, 2025	SEC EDGAR
Current report	8-K	Jun 11, 2025	Jun 12, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Fractyl Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Oct 5, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GUTS.

Compare: GUTS vs PFSA · GUTS vs PAVM · GUTS vs RDGL · GUTS vs QTEX · GUTS vs GIPL

Revenue growth-100.0% · median 35.2%

Company	Revenue	Growth
RDGL	$126.12K	+159.4%
PAVM	$112.00K	-89.0%
GIPL	$30.00K	–
GUTS	$0	-100.0%
PFSA	–	–
QTEX	–	–

Company

Next earnings (est.): Mar 23, 2027, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 100
Held by institutions: 4.3%
Auditor: Ernst & Young LLP
SEC CIK: 1572616

Advertisement
300 × 250

See a number that looks wrong?